William R Lykins

ORCID

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 13

Top Venues

Pharmaceutics

Human vaccines & immunotherapeutics

NPJ vaccines

ACS biomaterials science & engineering

This page only lists publications with an associated author ORCID identifier.

Publications

Mayuresh M Abhyankar, Feifan Xu, Deborah Chavez, Anna Goodroe, Elda Mendoza, Christopher Chen, Dhiraj K Singh, Fernando Varnador, Sandra J Sivananthan, Robert Kinsey, William R Lykins, Brynn M Murphy, Andrew R Martin, Mark A Tomai, Soutik Ghosal, Corey Casper, Karl Pedersen, William A Petri, Christopher B Fox
Immunogenicity and safety of an Entamoeba histolytica adjuvanted protein vaccine candidate (LecA+GLA-3M-052 liposomes) in rhesus macaques. Human vaccines & immunotherapeutics 20 (1) (2024)
Mayuresh M Abhyankar, Feifan Xu, Deborah Chavez, Anna Goodroe, Elda Mendoza, Christopher Chen, Dhiraj K Singh, Fernando Varnador, Sandra J Sivananthan, Robert Kinsey, William R Lykins, Brynn M Murphy, Andrew R Martin, Mark A Tomai, Soutik Ghosal, Corey Casper, Karl Pedersen, William A Petri, Christopher B Fox
Immunogenicity and safety of an Entamoeba histolytica adjuvanted protein vaccine candidate (LecA+GLA-3M-052 liposomes) in rhesus macaques. Human vaccines & immunotherapeutics 20 (1) (2024)
Mayuresh M Abhyankar, Feifan Xu, Deborah Chavez, Anna Goodroe, Elda Mendoza, Christopher Chen, Dhiraj K Singh, Fernando Varnador, Sandra J Sivananthan, Robert Kinsey, William R Lykins, Brynn M Murphy, Andrew R Martin, Mark A Tomai, Soutik Ghosal, Corey Casper, Karl Pedersen, William A Petri, Christopher B Fox
Immunogenicity and safety of an Entamoeba histolytica adjuvanted protein vaccine candidate (LecA+GLA-3M-052 liposomes) in rhesus macaques. Human vaccines & immunotherapeutics 20 (1) (2024)
Mayuresh M Abhyankar, Feifan Xu, Deborah Chavez, Anna Goodroe, Elda Mendoza, Christopher Chen, Dhiraj K Singh, Fernando Varnador, Sandra J Sivananthan, Robert Kinsey, William R Lykins, Brynn M Murphy, Andrew R Martin, Mark A Tomai, Soutik Ghosal, Corey Casper, Karl Pedersen, William A Petri, Christopher B Fox
Immunogenicity and safety of an Entamoeba histolytica adjuvanted protein vaccine candidate (LecA+GLA-3M-052 liposomes) in rhesus macaques. Human vaccines & immunotherapeutics 20 (1) (2024)
Karl J Fisher, Robert Kinsey, Raodoh Mohamath, Tony Phan, Hong Liang, Mark T Orr, William R Lykins, Jeffrey A Guderian, Julie Bakken, David Argilla, Gabi Ramer-Denisoff, Elise Larson, Yizhi Qi, Sandra Sivananthan, Karina Smolyar, Darrick Carter, Christopher J Paddon, Christopher B Fox
Semi-synthetic terpenoids with differential adjuvant properties as sustainable replacements for shark squalene in vaccine emulsions. NPJ vaccines 8 (1) (2023)
Karl J Fisher, Robert Kinsey, Raodoh Mohamath, Tony Phan, Hong Liang, Mark T Orr, William R Lykins, Jeffrey A Guderian, Julie Bakken, David Argilla, Gabi Ramer-Denisoff, Elise Larson, Yizhi Qi, Sandra Sivananthan, Karina Smolyar, Darrick Carter, Christopher J Paddon, Christopher B Fox
Semi-synthetic terpenoids with differential adjuvant properties as sustainable replacements for shark squalene in vaccine emulsions. NPJ vaccines 8 (1) (2023)
Karl J Fisher, Robert Kinsey, Raodoh Mohamath, Tony Phan, Hong Liang, Mark T Orr, William R Lykins, Jeffrey A Guderian, Julie Bakken, David Argilla, Gabi Ramer-Denisoff, Elise Larson, Yizhi Qi, Sandra Sivananthan, Karina Smolyar, Darrick Carter, Christopher J Paddon, Christopher B Fox
Semi-synthetic terpenoids with differential adjuvant properties as sustainable replacements for shark squalene in vaccine emulsions. NPJ vaccines 8 (1) (2023)
William R Lykins, Christopher B Fox
Practical Considerations for Next-Generation Adjuvant Development and Translation. Pharmaceutics 15 (7) (2023)
Hong Liang, William R Lykins, Emilie Seydoux, Jeffrey A Guderian, Tony Phan, Christopher B Fox, Mark T Orr
Formulated Phospholipids as Non-Canonical TLR4 Agonists. Pharmaceutics 14 (12) (2022)
Hong Liang, William R Lykins, Emilie Seydoux, Jeffrey A Guderian, Tony Phan, Christopher B Fox, Mark T Orr
Formulated Phospholipids as Non-Canonical TLR4 Agonists. Pharmaceutics 14 (12) (2022)
Hong Liang, William R Lykins, Emilie Seydoux, Jeffrey A Guderian, Tony Phan, Christopher B Fox, Mark T Orr
Formulated Phospholipids as Non-Canonical TLR4 Agonists. Pharmaceutics 14 (12) (2022)
Hong Liang, William R Lykins, Emilie Seydoux, Jeffrey A Guderian, Tony Phan, Christopher B Fox, Mark T Orr
Formulated Phospholipids as Non-Canonical TLR4 Agonists. Pharmaceutics 14 (12) (2022)
William R Lykins, M Eva Hansen, Xiaofei Sun, Rommel Advincula, Joel A Finbloom, Abhishek Kumar Jain, Yashoraj Zala, Averil Ma, Tejal A Desai
Impact of Microdevice Geometry on Transit and Retention in the Murine Gastrointestinal Tract. ACS biomaterials science & engineering (2021)

William R Lykins.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

William R Lykins